Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 6, Issue 6 (2017)

A PKPD interaction between oral hypoglycemic drug-rosiglitazone and trigonella foenum-graecum & histopathological study

Author(s):
Katakam Prakash and Muralidhar Nama
Abstract:
Trigonella foenum-graecum (Fenugreek plant) is a well-known traditionally used medicated herb, possesses different therapeutical activities. Fenugreek leaves have been used as traditional herbal medicines not only for hyperglycemia but also in hyperlipidimia, cellulitis and gastrointestinal disorders. Preliminary animal and human trials suggested the possible antihyperglycemic activity and antihyperlipidemic activity of Oral fenugreek leaf extract. T. foenum-graecum leaves have also previously been shown to have antihyperglycemic and hypocholesterolemic effects on Type I and Type II Diabetes mellitus patients and experimental induced diabetic animals. However, the research so far on the hypoglycemic effect of fenugreek couldn’t establish the optimum dose-level for experimental subjects. Hence, the research studies are required to study the pharmacodynamic and pharmacokinetic properties in order to determine the effect of fenugreek herb on the hyperglycemic patients who are taking the therapy with synthetic drugs. This study was taken up to discover the influence of Trigonella foenum-graecum on the pharmacokinetics and pharmacodynamics of Rosiglitazone in rats. Results have proven the negative (decrease) effect of Trigonella foenum-graecum on pharmacokinetics but positive (increase) effect on pharmacodynamics of Rosiglitazone.
Pages: 213-221  |  123 Views  36 Downloads


The Pharma Innovation Journal
How to cite this article:
Katakam Prakash, Muralidhar Nama. A PKPD interaction between oral hypoglycemic drug-rosiglitazone and trigonella foenum-graecum & histopathological study. Pharma Innovation 2017;6(6):213-221.

Call for book chapter